Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-15 HOOPER ANTHONY C Director Grant or award +12,922 37,414
2023-06-15 HOOPER ANTHONY C Director Grant or award · Share Option (Right to Buy) +26,975 26,975
2023-06-15 Glazer Donald W. Director Grant or award +12,922 2,784,143
2023-06-15 Glazer Donald W. Director Grant or award · Share Option (Right to Buy) +26,975 26,975
2023-06-15 Dugan Margaret Director Grant or award +12,922 29,614
2023-06-15 Dugan Margaret Director Grant or award · Share Option (Right to Buy) +26,975 26,975
2023-06-15 Lee Chan Henry SVP, General Counsel Grant or award +65,585 181,597
2023-06-15 Lee Chan Henry SVP, General Counsel Grant or award · Share Option (Right to Buy) +248,950 248,950
2023-06-15 Wang Lai Global Head of R&D Grant or award +133,627 1,614,431
2023-06-15 Wang Lai Global Head of R&D Grant or award · Share Option (Right to Buy) +507,234 507,234
2023-06-15 Wang Julia Aijun Chief Financial Officer Grant or award +107,770 342,303
2023-06-15 Wang Julia Aijun Chief Financial Officer Grant or award · Share Option (Right to Buy) +409,058 409,058
2023-06-15 Wu Xiaobin President, COO & GM China Grant or award +200,447 1,033,432
2023-06-15 Wu Xiaobin President, COO & GM China Grant or award · Share Option (Right to Buy) +760,851 760,851
2023-06-15 Wang Xiaodong Director Grant or award +86,216 5,531,328
2023-06-15 Wang Xiaodong Director Grant or award · Share Option (Right to Buy) +327,249 327,249
2023-06-15 OYLER JOHN Chief Executive Officer Grant or award +355,641 1,971,554
2023-06-15 OYLER JOHN Chief Executive Officer Grant or award · Share Option (Right to Buy) +1,349,907 1,349,907
2023-06-15 BAKER BROS. ADVISORS LP Director Grant or award +25,844 93,413
2023-06-15 BAKER BROS. ADVISORS LP Director Grant or award +25,844 93,417

Page 43 of 71 · 1,406 trades